BioStratum Challenges Affidavit Asserting Pre-1994 Pyridoxamine Product
This article was originally published in The Tan Sheet
Executive Summary
Hopeful pyridoxamine drug marketer BioStratum is skeptical of an affidavit submitted to FDA by Jarrow Formulas as evidence of the pre-1994 sale of pyridoxamine in supplements